<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.GN updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.GN</link>
    <description>q-bio.GN updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.GN" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Fri, 11 Oct 2024 04:00:08 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Fri, 11 Oct 2024 00:00:00 -0400</pubDate>
    <skipDays>
      <day>Saturday</day>
      <day>Sunday</day>
    </skipDays>
    <item>
      <title>Multilayer network approaches to omics data integration in Digital Twins for cancer research</title>
      <link>https://arxiv.org/abs/2410.07252</link>
      <description>arXiv:2410.07252v1 Announce Type: cross 
Abstract: This review examines current and potential applications of DTs in healthcare, focusing on the integration of multi-omics data using multilayer network approaches in cancer research. We discuss methodologies, tools and platforms commonly used for this integration, while highlighting case studies, challenges, and research gaps. Finally, we advocate the need for incorporating diverse data types to produce more effective DTs for personalization of cancer treatments and in silico clinical trials.</description>
      <guid isPermaLink="false">oai:arXiv.org:2410.07252v1</guid>
      <category>q-bio.MN</category>
      <category>q-bio.GN</category>
      <pubDate>Fri, 11 Oct 2024 00:00:00 -0400</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights>
      <dc:creator>Hugo Chenel (CRCT, Universit\'e de Toulouse, Inserm, CNRS, Universit\'e Toulouse III-Paul Sabatier, Centre de Recherches en Canc\'erologie de Toulouse, Toulouse, France, Evotec, Toulouse, France), Malvina Marku (CRCT, Universit\'e de Toulouse, Inserm, CNRS, Universit\'e Toulouse III-Paul Sabatier, Centre de Recherches en Canc\'erologie de Toulouse, Toulouse, France), Tim James (Evotec, Abingdon, Oxfordshire, UK), Andrei Zinovyev (Evotec, Toulouse, France), Vera Pancaldi (CRCT, Universit\'e de Toulouse, Inserm, CNRS, Universit\'e Toulouse III-Paul Sabatier, Centre de Recherches en Canc\'erologie de Toulouse, Toulouse, France)</dc:creator>
    </item>
  </channel>
</rss>
